These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37633752)

  • 1. Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study.
    Deng L; Tapper K; Thosar D; Goeman E; Baker L; Adelstein S; Boyle M; Brown DA; Evans L; Katelaris C; Lee F; Li J; Swaminathan S; Taylor MS; Wong M; Wood N
    Vaccine; 2023 Sep; 41(41):5987-5993. PubMed ID: 37633752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.
    Fitzpatrick T; Yamoah P; Lacuesta G; Sadarangani M; Cook V; Pourshahnazari P; Kalicinsky C; Upton JEM; Cameron SB; Zaborniak K; Kanani A; Lam G; Burton C; Constantinescu C; Pernica JM; Abdurrahman Z; Betschel S; Drolet JP; De Serres G; Quach C; Des Roches A; Chapdelaine H; Salvadori MI; Carignan A; McConnell A; Pham-Huy A; Buchan CA; Cowan J; Hildebrand K; Top KA;
    Vaccine; 2024 Oct; 42(24):126078. PubMed ID: 38910092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.
    Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW
    Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021.
    Shivarev A; Phillips A; Brophy-Williams S; Ford T; Richmond P; Effler P; McLean-Tooke A
    Intern Med J; 2023 Feb; 53(2):275-279. PubMed ID: 36585764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
    Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D
    Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021.
    Lee E; Lee YK; Kim TE; Hwang I; Jung YH; Lee HR; Song J; Park Y; Cho E; Lee YK
    Euro Surveill; 2021 Aug; 26(33):. PubMed ID: 34414880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-related Anaphylaxis Cases Confirmed by KCDC from 2001-2016.
    Roh EJ; Lee MH; Song KB; Lee YK; Kim MK; Kim TE; Chung EH
    J Korean Med Sci; 2020 Sep; 35(38):e337. PubMed ID: 32989932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
    Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
    JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance.
    Maltezou HC; Hatziantoniou S; Theodoridou K; Vasileiou K; Anastassopoulou C; Tsakris A
    Vaccine; 2023 Mar; 41(14):2382-2386. PubMed ID: 36872145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine.
    Rouleau I; De Serres G; Drolet JP; Skowronski DM; Ouakki M; Toth E; Landry M; Ménard S; Gagnon R
    Vaccine; 2013 Dec; 31(50):5989-96. PubMed ID: 24144473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis: Revision of the Brighton collaboration case definition.
    Gold MS; Amarasinghe A; Greenhawt M; Kelso JM; Kochhar S; Yu-Hor Thong B; Top KA; Turner PJ; Worm M; Law B
    Vaccine; 2023 Apr; 41(15):2605-2614. PubMed ID: 36435707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.
    Almohaya AM; Alsubie H; Alqarni B; Alzayad B; Alghar A; Alshahrani K; Barry M
    Vaccine; 2022 Jan; 40(3):477-482. PubMed ID: 34916104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data.
    Arcolaci A; Bronte V; Zanoni G
    Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):418-425. PubMed ID: 34269740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic Reactions After the Administration of COVID-19 Vaccines.
    Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B
    Front Public Health; 2022; 10():878081. PubMed ID: 35655467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.